Traduction de «produit marginal de substitution » (Français → Anglais) :

The objective is twofold: on the one hand, enabling the European industry (e.g. chemical, health, mining, energy, pulp and paper, fibre-based products and wood, textile, starch, and food processing industries) to develop new products and processes meeting industrial and societal demands using preferably environmentally friendly and sustainable production methods and competitive and enhanced biotechnology-based alternatives to replace established ones; on the other hand, harnessing the potential of biotechnology for detecting, monitoring, preventing and removing pollution.

Any authorisation of plant protection products containing a candidate for substitution without comparative assessment should be limited to three years maximum.

(13)(11) Exemptions from the substitution requirement should be permitted if substitution is not possible from the scientific and technical point of view ð , taking specific account of the situation of SMEs ï or if the negative environmental, or health ð or socio-economic ï impacts caused by substitution are likely to outweigh the human the health, and environmental ð or socio-economic ï benefits of the substitution. ð or the availability and reliability of substitutes is not ensured. ï Substitution of the hazardous substances in electrical and electronic equipment should also be carried out in a way so as to be compatible with the healt ...[+++]h and safety of users of electrical and electronic equipment ð The placing on the market of medical devices requires a conformity assessment procedure, according to Directives 93/42/EC and 98/79/EC, which could require the involvement of a notified body designated by Competent Authorities of Member States.

Having disregarded the availability of safer substitutes, the Commission had to concede in a study in 2007 that "substitutes do exist on the market .and that literature data suggest that potential adverse environmental and human health effects of at least some substitutes may be minimal".

At the same time, as a question of principle, no long-term derogation is necessary as the manufacturers have ample time to adapt in the case of safe alternative chemicals without the need to introduce a risky precedent in safety directives.

At the same time, as a question of principle, no long-term derogation is necessary as the manufacturers have ample time to adapt in the case of safe alternative chemicals without the need to introduce a risky precedent in safety directives.